These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 22751655)

  • 1. Improved outcomes in heart failure treated with high-dose ACE inhibitors and ARBs: a population-based study.
    Egiziano G; Pilote L; Behlouli H; Daskalopoulou SS
    Arch Intern Med; 2012 Sep; 172(16):1263-5. PubMed ID: 22751655
    [No Abstract]   [Full Text] [Related]  

  • 2. Sex differences in the effectiveness of angiotensin receptor blockers and angiotensin converting enzyme inhibitors in patients with congestive heart failure--a population study.
    Hudson M; Rahme E; Behlouli H; Sheppard R; Pilote L
    Eur J Heart Fail; 2007; 9(6-7):602-9. PubMed ID: 17383932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discharge use of angiotensin receptor blockers provides comparable effects with angiotensin-converting enzyme inhibitors on outcomes in patients hospitalized for heart failure.
    Tsuchihashi-Makaya M; Furumoto T; Kinugawa S; Hamaguchi S; Goto K; Goto D; Yamada S; Yokoshiki H; Takeshita A; Tsutsui H;
    Hypertens Res; 2010 Mar; 33(3):197-202. PubMed ID: 19960016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [ACE inhibitors continue to be first choice in the treatment of heart failure patients].
    Gadsbøll N; Pedersen CT
    Ugeskr Laeger; 2013 May; 175(22):1566-8. PubMed ID: 23721841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers and cardiovascular outcomes in chronic dialysis patients: a population-based cohort study.
    Bajaj RR; Wald R; Hackam DG; Gomes T; Perl J; Juurlink DN; Manno M; Garg AX; Kitchlu A; Mamdani MM; Yan AT
    Arch Intern Med; 2012 Apr; 172(7):591-3. PubMed ID: 22493468
    [No Abstract]   [Full Text] [Related]  

  • 6. Influence of order and type of drug (bisoprolol vs. enalapril) on outcome and adverse events in patients with chronic heart failure: a post hoc analysis of the CIBIS-III trial.
    Funck-Brentano C; van Veldhuisen DJ; van de Ven LL; Follath F; Goulder M; Willenheimer R;
    Eur J Heart Fail; 2011 Jul; 13(7):765-72. PubMed ID: 21551161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Designing a comprehensive strategy to improve one core measure: discharge of patients with myocardial infarction or heart failure on ACE inhibitors/ARBs.
    Santana C; Shaines M; Choi P; Bhalla R
    Am J Med Qual; 2012; 27(5):398-405. PubMed ID: 22345132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relation of dosing of the renin-angiotensin system inhibitors after cardiac resynchronization therapy to long-term prognosis.
    Mantziari L; Guha K; Khalique Z; McDonagh T; Sharma R
    Am J Cardiol; 2012 Jun; 109(11):1619-25. PubMed ID: 22465318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with congestive heart failure and chronic kidney disease.
    Berger AK; Duval S; Manske C; Vazquez G; Barber C; Miller L; Luepker RV
    Am Heart J; 2007 Jun; 153(6):1064-73. PubMed ID: 17540211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heart failure patients receiving ACEIs/ARBs were less likely to be hospitalized or to use emergency care in the following year.
    Chen JY; Kang N; Juarez DT; Yermilov I; Braithwaite RS; Hodges KA; Legorreta A; Chung RS
    J Healthc Qual; 2011; 33(4):29-36. PubMed ID: 21733022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Efficacy of angiotensin II receptor antagonists as a novel drug for the treatment of chronic heart failure--in comparison with ACE inhibitors].
    Kitakaze M; Kuzuya T; Hori M
    Nihon Rinsho; 1999 May; 57(5):1148-57. PubMed ID: 10361449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin-converting enzyme inhibitor use in elderly patients hospitalized with heart failure and left ventricular systolic dysfunction.
    Rangaswamy C; Finn JI; Koelling TM
    Cardiology; 2005; 103(1):17-23. PubMed ID: 15528896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patterns and predictors of evidence-based medication continuation among hospitalized heart failure patients (from Get With the Guidelines-Heart Failure).
    Krantz MJ; Ambardekar AV; Kaltenbach L; Hernandez AF; Heidenreich PA; Fonarow GC;
    Am J Cardiol; 2011 Jun; 107(12):1818-23. PubMed ID: 21482418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Of fads, fashion, surrogate endpoints and dual RAS blockade.
    Messerli FH; Staessen JA; Zannad F
    Eur Heart J; 2010 Sep; 31(18):2205-8. PubMed ID: 20685681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Should angiotensin receptor blockers be added to angiotensin-converting enzyme inhibitors in the treatment of heart failure?
    Ghanem FA; Movahed A
    Rev Cardiovasc Med; 2005; 6(4):206-13. PubMed ID: 16379016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ACE inhibitors vs ARBs: is one class better for heart failure.
    Dunlap ME; Peterson RC
    Cleve Clin J Med; 2002 May; 69(5):433-8. PubMed ID: 12022388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Renin-angiotensin system as a potential target for the treatment with heart failure: ACE inhibitors, angiotensin-II receptor blockers and aldosterone antagonists].
    Sanada S; Kitakaze M
    Nihon Rinsho; 2003 May; 61(5):821-6. PubMed ID: 12755009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin-converting enzyme inhibitors and survival in women and men with heart failure.
    Keyhan G; Chen SF; Pilote L
    Eur J Heart Fail; 2007; 9(6-7):594-601. PubMed ID: 17462947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in clinical practice.
    Barrios V; Coca A; Escobar C; Enrique R; Rincón LM
    Expert Rev Cardiovasc Ther; 2012 Feb; 10(2):159-66. PubMed ID: 22292872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Role of RAAS inhibitors for the treatment of heart failure].
    Murohara T
    Nihon Rinsho; 2012 Sep; 70(9):1577-81. PubMed ID: 23012806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.